S&P 500   4,535.26 (+0.35%)
DOW   35,603.58 (+0.41%)
QQQ   375.05 (-0.11%)
AAPL   148.91 (+0.10%)
MSFT   307.56 (-0.22%)
FB   340.89 (+0.26%)
GOOGL   2,838.40 (-0.92%)
TSLA   865.03 (+0.09%)
AMZN   3,420.90 (-0.68%)
NVDA   220.70 (-0.99%)
BABA   177.49 (+0.28%)
NIO   39.71 (-0.80%)
CGC   14.17 (-1.19%)
GE   105.61 (+0.84%)
AMD   116.29 (-0.03%)
MU   68.57 (+1.48%)
T   25.94 (+1.37%)
F   15.96 (+3.50%)
ACB   7.57 (+1.61%)
DIS   170.61 (-0.33%)
PFE   42.80 (+1.69%)
BA   216.26 (+0.13%)
AMC   40.99 (+0.47%)
S&P 500   4,535.26 (+0.35%)
DOW   35,603.58 (+0.41%)
QQQ   375.05 (-0.11%)
AAPL   148.91 (+0.10%)
MSFT   307.56 (-0.22%)
FB   340.89 (+0.26%)
GOOGL   2,838.40 (-0.92%)
TSLA   865.03 (+0.09%)
AMZN   3,420.90 (-0.68%)
NVDA   220.70 (-0.99%)
BABA   177.49 (+0.28%)
NIO   39.71 (-0.80%)
CGC   14.17 (-1.19%)
GE   105.61 (+0.84%)
AMD   116.29 (-0.03%)
MU   68.57 (+1.48%)
T   25.94 (+1.37%)
F   15.96 (+3.50%)
ACB   7.57 (+1.61%)
DIS   170.61 (-0.33%)
PFE   42.80 (+1.69%)
BA   216.26 (+0.13%)
AMC   40.99 (+0.47%)
S&P 500   4,535.26 (+0.35%)
DOW   35,603.58 (+0.41%)
QQQ   375.05 (-0.11%)
AAPL   148.91 (+0.10%)
MSFT   307.56 (-0.22%)
FB   340.89 (+0.26%)
GOOGL   2,838.40 (-0.92%)
TSLA   865.03 (+0.09%)
AMZN   3,420.90 (-0.68%)
NVDA   220.70 (-0.99%)
BABA   177.49 (+0.28%)
NIO   39.71 (-0.80%)
CGC   14.17 (-1.19%)
GE   105.61 (+0.84%)
AMD   116.29 (-0.03%)
MU   68.57 (+1.48%)
T   25.94 (+1.37%)
F   15.96 (+3.50%)
ACB   7.57 (+1.61%)
DIS   170.61 (-0.33%)
PFE   42.80 (+1.69%)
BA   216.26 (+0.13%)
AMC   40.99 (+0.47%)
S&P 500   4,535.26 (+0.35%)
DOW   35,603.58 (+0.41%)
QQQ   375.05 (-0.11%)
AAPL   148.91 (+0.10%)
MSFT   307.56 (-0.22%)
FB   340.89 (+0.26%)
GOOGL   2,838.40 (-0.92%)
TSLA   865.03 (+0.09%)
AMZN   3,420.90 (-0.68%)
NVDA   220.70 (-0.99%)
BABA   177.49 (+0.28%)
NIO   39.71 (-0.80%)
CGC   14.17 (-1.19%)
GE   105.61 (+0.84%)
AMD   116.29 (-0.03%)
MU   68.57 (+1.48%)
T   25.94 (+1.37%)
F   15.96 (+3.50%)
ACB   7.57 (+1.61%)
DIS   170.61 (-0.33%)
PFE   42.80 (+1.69%)
BA   216.26 (+0.13%)
AMC   40.99 (+0.47%)
NASDAQ:IBB

iShares Nasdaq Biotechnology ETF Stock Forecast, Price & News

$157.84
+0.44 (+0.28 %)
(As of 10/20/2021 03:16 PM ET)
Add
Compare
Today's Range
$157.40
$158.74
50-Day Range
$153.92
$176.00
52-Week Range
$128.23
$177.37
Volume158,540 shs
Average Volume3.05 million shs
Market Capitalization$10.14 billion
P/E RatioN/A
Dividend Yield0.22%
Beta0.93
30 days | 90 days | 365 days | Advanced Chart
Receive IBB News and Ratings via Email

Sign-up to receive the latest news and ratings for iShares Nasdaq Biotechnology ETF and its competitors with MarketBeat's FREE daily newsletter.

Basic Details

Issuer BlackRock
Fund NameiShares Nasdaq Biotechnology ETF
Tax ClassificationRegulated Investment Company
SymbolNASDAQ:IBB
Inception Date2/5/2001
Fund ManagerDiane Hsiung, Jennifer Hsui, Greg Savage, Alan Mason
WebN/A
PhoneN/A

Fund Focus

Asset ClassEquity
BenchmarkNASDAQ Biotechnology Index
CategorySector
FocusHealth Care
Development LevelDeveloped Markets
RegionNorth America

Fund Statistics

Assets Under Management$7.70 billion
Average Daily Volume$2.62 million
Discount/Premium0.08%

ETF Expenses

Management Fee0.47%
Other Expenses0.00%
Total Expenses0.47%
Fee Waiver0.00%
Net Expenses0.47%

Administrator, Advisor and Custodian

AdministratorState Street Bank and Trust Company
AdvisorBlackRock Fund Advisors
CustodianState Street Bank and Trust Company
DistributorBlackRock Investments, LLC
Transfer AgentState Street Bank and Trust Company
Trustee
Lead Market MakerVirtu Financial

Geographic Exposure of IBB

Currency Exposure of IBB

Sector Exposure of IBB

Industry Exposure of IBB













iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) Frequently Asked Questions

What stocks does MarketBeat like better than iShares Nasdaq Biotechnology ETF?

Wall Street analysts have given iShares Nasdaq Biotechnology ETF a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but iShares Nasdaq Biotechnology ETF wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

How has iShares Nasdaq Biotechnology ETF's stock been impacted by Coronavirus?

iShares Nasdaq Biotechnology ETF's stock was trading at $106.97 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, IBB stock has increased by 47.6% and is now trading at $157.92.
View which stocks have been most impacted by COVID-19
.

How often does iShares Nasdaq Biotechnology ETF pay dividends? What is the dividend yield for iShares Nasdaq Biotechnology ETF?

iShares Nasdaq Biotechnology ETF declared a quarterly dividend on Thursday, September 23rd. Stockholders of record on Monday, September 27th will be paid a dividend of $0.124 per share on Thursday, September 30th. This represents a $0.50 dividend on an annualized basis and a dividend yield of 0.31%. The ex-dividend date is Friday, September 24th. This is a positive change from iShares Nasdaq Biotechnology ETF's previous quarterly dividend of $0.06.
View iShares Nasdaq Biotechnology ETF's dividend history
.

Is iShares Nasdaq Biotechnology ETF a good dividend stock?

iShares Nasdaq Biotechnology ETF pays an annual dividend of $0.34 per share and currently has a dividend yield of 0.22%.
View iShares Nasdaq Biotechnology ETF's dividend history.

When did iShares Nasdaq Biotechnology ETF's stock split? How did iShares Nasdaq Biotechnology ETF's stock split work?

iShares Nasdaq Biotechnology ETF's stock split on the morning of Friday, December 1st 2017. The 3-1 split was announced on Tuesday, November 7th 2017. The newly issued shares were issued to shareholders after the closing bell on Thursday, November 30th 2017. An investor that had 100 shares of iShares Nasdaq Biotechnology ETF stock prior to the split would have 300 shares after the split.

Who are iShares Nasdaq Biotechnology ETF's key executives?

iShares Nasdaq Biotechnology ETF's management team includes the following people:
  • George G. C. Parker Ph.D., Independent Chairman of the Board of Trustees
  • Michael Arthur Latham, President, Trustee
  • Jack Gee, Chief Financial Officer, Treasurer
  • Geoffrey D. Flynn, Chief Operating Officer, Executive Vice President
  • , Bio & Compensation - 
  • Amy Schioldager, Executive Vice President
  • Ira P. Shapiro, Vice President, Chief Legal Officer
  • Matt Tucker, Vice President
  • , Bio & Compensation - 
  • Eilleen M. Clavere, Secretary
  • Cecilia H. Herbert, Independent Trustee
  • Charles A. Hurty, Independent Trustee

Who are some of iShares Nasdaq Biotechnology ETF's key competitors?

What other stocks do shareholders of iShares Nasdaq Biotechnology ETF own?

Based on aggregate information from My MarketBeat watchlists, some companies that other iShares Nasdaq Biotechnology ETF investors own include NVIDIA (NVDA), The Walt Disney (DIS), Netflix (NFLX), Alibaba Group (BABA), Tesla (TSLA), Cisco Systems (CSCO), Micron Technology (MU), Bank of America (BAC), Johnson & Johnson (JNJ) and PayPal (PYPL).

What is iShares Nasdaq Biotechnology ETF's stock symbol?

iShares Nasdaq Biotechnology ETF trades on the NASDAQ under the ticker symbol "IBB."

Who are iShares Nasdaq Biotechnology ETF's major shareholders?

iShares Nasdaq Biotechnology ETF's stock is owned by a number of retail and institutional investors. Top institutional shareholders include SpiderRock Advisors LLC (0.00%), Albion Financial Group UT (0.18%), Rye Brook Capital LLC (0.10%), McGuire Investment Group LLC (0.10%), Toth Financial Advisory Corp (0.10%) and CHURCHILL MANAGEMENT Corp (0.09%).

Which institutional investors are selling iShares Nasdaq Biotechnology ETF stock?

IBB stock was sold by a variety of institutional investors in the last quarter, including Altfest L J & Co. Inc., Stratos Wealth Advisors LLC, CHURCHILL MANAGEMENT Corp, Pinnacle Associates Ltd., CAPROCK Group Inc., M&R Capital Management Inc., NEXT Financial Group Inc, and Founders Capital Management.

Which institutional investors are buying iShares Nasdaq Biotechnology ETF stock?

IBB stock was bought by a variety of institutional investors in the last quarter, including Albion Financial Group UT, Crescent Capital Consulting LLC, Kestra Advisory Services LLC, Private Advisor Group LLC, Rye Brook Capital LLC, Latitude Advisors LLC, Koshinski Asset Management Inc., and Canton Hathaway LLC.

How do I buy shares of iShares Nasdaq Biotechnology ETF?

Shares of IBB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is iShares Nasdaq Biotechnology ETF's stock price today?

One share of IBB stock can currently be purchased for approximately $157.92.

How much money does iShares Nasdaq Biotechnology ETF make?

iShares Nasdaq Biotechnology ETF has a market capitalization of $10.15 billion.


This page was last updated on 10/20/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.